241 related articles for article (PubMed ID: 10231164)
1. A pooled analysis of case-control studies of thyroid cancer. III. Oral contraceptives, menopausal replacement therapy and other female hormones.
La Vecchia C; Ron E; Franceschi S; Dal Maso L; Mark SD; Chatenoud L; Braga C; Preston-Martin S; McTiernan A; Kolonel L; Mabuchi K; Jin F; Wingren G; Galanti MR; Hallquist A; Lund E; Levi F; Linos D; Negri E
Cancer Causes Control; 1999 Apr; 10(2):157-66. PubMed ID: 10231164
[TBL] [Abstract][Full Text] [Related]
2. A pooled analysis of case-control studies of thyroid cancer. II. Menstrual and reproductive factors.
Negri E; Dal Maso L; Ron E; La Vecchia C; Mark SD; Preston-Martin S; McTiernan A; Kolonel L; Yoshimoto Y; Jin F; Wingren G; Rosaria Galanti M; Hardell L; Glattre E; Lund E; Levi F; Linos D; Braga C; Franceschi S
Cancer Causes Control; 1999 Apr; 10(2):143-55. PubMed ID: 10231163
[TBL] [Abstract][Full Text] [Related]
3. Incidence of thyroid cancer in women in relation to reproductive and hormonal factors.
McTiernan AM; Weiss NS; Daling JR
Am J Epidemiol; 1984 Sep; 120(3):423-35. PubMed ID: 6475918
[TBL] [Abstract][Full Text] [Related]
4. A pooled analysis of case-control studies of thyroid cancer. I. Methods.
Negri E; Ron E; Franceschi S; Dal Maso L; Mark SD; Preston-Martin S; McTiernan A; Kolonel L; Kleinerman R; Land C; Jin F; Wingren G; Galanti MR; Hallquist A; Glattre E; Lund E; Levi F; Linos D; Braga C; La Vecchia C
Cancer Causes Control; 1999 Apr; 10(2):131-42. PubMed ID: 10231162
[TBL] [Abstract][Full Text] [Related]
5. Oral contraceptives and breast cancer risk in Taiwan, a country of low incidence of breast cancer and low use of oral contraceptives.
Chie WC; Li CY; Huang CS; Chang KJ; Yen ML; Lin RS
Int J Cancer; 1998 Jul; 77(2):219-23. PubMed ID: 9650556
[TBL] [Abstract][Full Text] [Related]
6. Use of exogenous hormones hormones and risk of papillary thyroid cancer (Washington, United States).
Rossing MA; Voigt LF; Wicklund KG; Williams M; Daling JR
Cancer Causes Control; 1998 May; 9(3):341-9. PubMed ID: 9684714
[TBL] [Abstract][Full Text] [Related]
7. Population-based study of risk of venous thromboembolism associated with various oral contraceptives.
Farmer RD; Lawrenson RA; Thompson CR; Kennedy JG; Hambleton IR
Lancet; 1997 Jan; 349(9045):83-8. PubMed ID: 8996419
[TBL] [Abstract][Full Text] [Related]
8. The use of oral contraceptives and the occurrence of acute myocardial infarction in young women. Results from the Transnational Study on Oral Contraceptives and the Health of Young Women.
Lewis MA; Heinemann LA; Spitzer WO; MacRae KD; Bruppacher R
Contraception; 1997 Sep; 56(3):129-40. PubMed ID: 9347202
[TBL] [Abstract][Full Text] [Related]
9. A pooled analysis of case-control studies of thyroid cancer. IV. Benign thyroid diseases.
Franceschi S; Preston-Martin S; Dal Maso L; Negri E; La Vecchia C; Mack WJ; McTiernan A; Kolonel L; Mark SD; Mabuchi K; Jin F; Wingren G; Galanti R; Hallquist A; Glattre E; Lund E; Levi F; Linos D; Ron E
Cancer Causes Control; 1999 Dec; 10(6):583-95. PubMed ID: 10616827
[TBL] [Abstract][Full Text] [Related]
10. Oral contraceptive use and risk of colorectal cancer.
Fernandez E; La Vecchia C; Franceschi S; Braga C; Talamini R; Negri E; Parazzini F
Epidemiology; 1998 May; 9(3):295-300. PubMed ID: 9583422
[TBL] [Abstract][Full Text] [Related]
11. Oral contraceptives and breast cancer: a cooperative Italian study.
La Vecchia C; Negri E; Franceschi S; Talamini R; Amadori D; Filiberti R; Conti E; Montella M; Veronesi A; Parazzini F
Int J Cancer; 1995 Jan; 60(2):163-7. PubMed ID: 7829209
[TBL] [Abstract][Full Text] [Related]
12. Reproductive and menstrual history and papillary thyroid cancer risk: the San Francisco Bay Area thyroid cancer study.
Sakoda LC; Horn-Ross PL
Cancer Epidemiol Biomarkers Prev; 2002 Jan; 11(1):51-7. PubMed ID: 11815401
[TBL] [Abstract][Full Text] [Related]
13. Sex steroid hormones and breast cancer: is there a link with oral contraceptives and hormone replacement therapy?
Khoo SK; Chick P
Med J Aust; 1992 Jan; 156(2):124-32. PubMed ID: 1736053
[TBL] [Abstract][Full Text] [Related]
14. Oral contraceptive use and other risk factors in relation to HER-2/neu overexpression in breast cancer among young women.
Gammon MD; Hibshoosh H; Terry MB; Bose S; Schoenberg JB; Brinton LA; Bernstein JL; Thompson WD
Cancer Epidemiol Biomarkers Prev; 1999 May; 8(5):413-9. PubMed ID: 10350436
[TBL] [Abstract][Full Text] [Related]
15. Reproductive history and cigarette smoking as risk factors for thyroid cancer in women: a population-based case-control study.
Galanti MR; Hansson L; Lund E; Bergström R; Grimelius L; Stalsberg H; Carlsen E; Baron JA; Persson I; Ekbom A
Cancer Epidemiol Biomarkers Prev; 1996 Jun; 5(6):425-31. PubMed ID: 8781737
[TBL] [Abstract][Full Text] [Related]
16. Female hormone utilisation and risk of hepatocellular carcinoma.
Tavani A; Negri E; Parazzini F; Franceschi S; La Vecchia C
Br J Cancer; 1993 Mar; 67(3):635-7. PubMed ID: 8382515
[TBL] [Abstract][Full Text] [Related]
17. Oral contraceptives and breast cancer.
Brinton LA; Hoover R; Szklo M; Fraumeni JF
Int J Epidemiol; 1982 Dec; 11(4):316-22. PubMed ID: 7152784
[TBL] [Abstract][Full Text] [Related]
18. Reproductive factors, menopausal hormone therapies and primary liver cancer risk: a systematic review and dose-response meta-analysis of observational studies.
Zhong GC; Liu Y; Chen N; Hao FB; Wang K; Cheng JH; Gong JP; Ding X
Hum Reprod Update; 2016 Dec; 23(1):126-138. PubMed ID: 27655589
[TBL] [Abstract][Full Text] [Related]
19. Acute myocardial infarction and combined oral contraceptives: results of an international multicentre case-control study. WHO Collaborative Study of Cardiovascular Disease and Steroid Hormone Contraception.
Lancet; 1997 Apr; 349(9060):1202-9. PubMed ID: 9130941
[TBL] [Abstract][Full Text] [Related]
20. Oral contraceptives and breast cancer.
Jick H; Walker AM; Watkins RN; D'Ewart DC; Hunter JR; Danford A; Madsen S; Dinan BJ; Rothman KJ
Am J Epidemiol; 1980 Nov; 112(5):577-85. PubMed ID: 7435486
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
